, the maker of the drug, want the nation’s highest court to reject limits on mifepristone’s use imposed by lower courts, at least as long as the legal case makes it way through the courts. They say women who want the drug and providers who dispense it will face chaos if limits on the drug take effect. Depending on what the justices decide, that could include requiring women to take a higher dosage of the drug than the FDA says is necessary.
Less than a week later, a federal appeals court modified the ruling so that mifepristone would remain available while the case continues, but with limits. The appeals court said that the drug can’t be mailed or dispensed as a generic and that patients who seek it need to make three in-person visits with a doctor, among other things.
Complicating the situation, a federal judge in Washington has ordered the FDA to preserve access to mifepristone under the current rules in 17 Democratic-led states and the District of Columbia that filed a separate lawsuit.
Alito will most likely refer the case to the full court, which has a 6-3 conservative majority. JudiciaryGOP 🇺🇸 SCOTUSblog
not their damn business..
Should Ketanji recuse herself from this as she doesn't know what a woman is?
What they don't want you to know about Mifepristone...there are so many serious life threatening side effects that not only is it limited to prescription only, it can only be prescribed if the doctor and the pharmacy participate in a special Risk Evaluation and Mitigation…
I do not think that an MAB is more common than an SAB in the United States.
Ahhh, Patriarchy....gotta love the way they think a woman's body is the jurisdiction of the State.
The suspense...gee, I wonder which way this vote will go.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNN - 🏆 4. / 95 Read more »
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »
Source: wttw - 🏆 520. / 51 Read more »
Source: dcexaminer - 🏆 6. / 94 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: News4SA - 🏆 251. / 63 Read more »